CZ233892A3 - Compound a87689, process of their preparation and a pharmaceutical composition in which said compound is comprised - Google Patents

Compound a87689, process of their preparation and a pharmaceutical composition in which said compound is comprised Download PDF

Info

Publication number
CZ233892A3
CZ233892A3 CS922338A CS233892A CZ233892A3 CZ 233892 A3 CZ233892 A3 CZ 233892A3 CS 922338 A CS922338 A CS 922338A CS 233892 A CS233892 A CS 233892A CZ 233892 A3 CZ233892 A3 CZ 233892A3
Authority
CZ
Czechia
Prior art keywords
compound
salt
nrrl
compounds
cells
Prior art date
Application number
CS922338A
Other languages
Czech (cs)
English (en)
Inventor
Dennis Randolph Berry
Anne Hollins Dantzig
Manuel Debono
Robert L Hamill
Robert Michael Molloy Sr
Raymond Che-Fong Yao
Joseph Matthew Colacino
Chiou-Chung Tang Joseph
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CZ233892A3 publication Critical patent/CZ233892A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS922338A 1991-08-01 1992-07-24 Compound a87689, process of their preparation and a pharmaceutical composition in which said compound is comprised CZ233892A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73896991A 1991-08-01 1991-08-01
US88972292A 1992-05-28 1992-05-28

Publications (1)

Publication Number Publication Date
CZ233892A3 true CZ233892A3 (en) 1993-02-17

Family

ID=27113454

Family Applications (1)

Application Number Title Priority Date Filing Date
CS922338A CZ233892A3 (en) 1991-08-01 1992-07-24 Compound a87689, process of their preparation and a pharmaceutical composition in which said compound is comprised

Country Status (14)

Country Link
EP (1) EP0526258A2 (enExample)
JP (1) JPH05213999A (enExample)
KR (1) KR930004460A (enExample)
CN (1) CN1073979A (enExample)
AU (1) AU2072092A (enExample)
BR (1) BR9202993A (enExample)
CA (1) CA2075163A1 (enExample)
CZ (1) CZ233892A3 (enExample)
FI (1) FI923487L (enExample)
HU (1) HUT65398A (enExample)
IL (1) IL102679A0 (enExample)
MX (1) MX9204419A (enExample)
NO (1) NO923029L (enExample)
YU (1) YU75192A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055814A1 (en) * 2010-10-25 2012-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910002457A (ko) * 1989-07-10 1991-02-25 원본미기재 항 비루스 항생제 bu-3889v

Also Published As

Publication number Publication date
CN1073979A (zh) 1993-07-07
MX9204419A (es) 1993-02-01
FI923487A0 (fi) 1992-07-31
BR9202993A (pt) 1993-03-30
HU9202478D0 (en) 1992-10-28
IL102679A0 (en) 1993-01-14
AU2072092A (en) 1993-02-04
EP0526258A2 (en) 1993-02-03
KR930004460A (ko) 1993-03-22
JPH05213999A (ja) 1993-08-24
CA2075163A1 (en) 1993-02-02
YU75192A (sh) 1995-10-03
HUT65398A (en) 1994-06-28
FI923487A7 (fi) 1993-02-02
EP0526258A3 (enExample) 1994-04-27
NO923029L (no) 1993-02-02
NO923029D0 (no) 1992-07-31
FI923487L (fi) 1993-02-02

Similar Documents

Publication Publication Date Title
BG61205B2 (bg) Хипохолестеринови ферментационни продукти и метод за получаването им
KR840000750B1 (ko) 폴리에테르 화합물
JPH029381A (ja) 抗生物質
CH636903A5 (fr) Antibiotiques de desoxynarasine.
US5350579A (en) A87689 compounds employed as a phospholipase A2 (PLA2) inhibitor to treat inflammatory diseases
US5266600A (en) BU-4641V, an antibacterial, antiviral and antitumor antibiotic
CZ233892A3 (en) Compound a87689, process of their preparation and a pharmaceutical composition in which said compound is comprised
US5278064A (en) Amycolatopsis mediterranei strains useful to prepare A87689 compounds
US6608045B2 (en) Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient
EP0116690A1 (en) Antiviral composition containing an indole-N-glycoside
US5286649A (en) Antiviral antibiotic BU-3889V
KR20120079281A (ko) 펩티드 디포밀라제 저해 및 항균 활성을 갖는 신규한 프라비마이신 화합물
US5098708A (en) Antiviral antibiotic BU-3889V
US5827872A (en) Xenomins novel heterocyclic compounds with antimicrobial and antneoplastic properties
HU204893B (en) Process for producing polyether antibiotics and pharmaceutical compositions comprising same
WO2009141786A2 (en) Anti-inflammatory compounds
US5124150A (en) Process for preparing antiviral antibiotic BU-3889V
EP0603031A2 (en) Antiviral antibiotic BU-4724V and preparation thereof
KR100912138B1 (ko) 펩타이드 디포밀라제 저해 및 항균 활성을 갖는 신규한 마크로락틴계 화합물
EP0603030A2 (en) Antiviral antibiotic BU-4628V and preparation thereof
DK173449B1 (da) Anvendelse af et benanomicinderivat til fremstilling af et antiviralt lægemiddel
IE902495A1 (en) ANTIVIRAL ANTIBIOTIC Bu-3889V
CA1163938A (en) Process for treating a protozoan disease with lincomycin 3-(5'-ribonucleotides)
DK142061B (da) Fremgangsmåde til fremstilling af antibiotikum A-28086-kompleks, dets komponenter faktor A, faktor B og faktor D eller salte eller estere deraf.
US8039454B2 (en) Macrolide compounds with antibiotic and antineoplastic properties